Recombinant human EGF protein (Active) ab259398 from Abcam

Product Specs
ItemRecombinant human EGF protein (Active)
CompanyAbcam
Price $135.00Supplier Page View Company Product Page
Catalog Numberab259398
Size10 µg, 50 µg, 100 µg, 250 µg
ActivityActive
ApplicationsCell Culture, FuncS, HPLC, Mass Spec, SDS-PAGE
FormatLyophilised
SpeciesHuman
Source/Expression SystemHEK 293 cells
NCBI Gene AliasesHOMG4, URG
Gene NameEGF
Research AreaOncology
NCBI Full Gene Nameepidermal growth factor
TypeProteins
Molecule NameEGF

Add to Compare List

Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

Company Profile

Website: http://www.abcam.com

(1) The promoting roles of GLP1R and GIPR in stemness maintenance and multiple lineage-specific differentiation of PDLSCsCell Mol Biol LettFebruary 11, 2026Yifen Shen, Mengjie Zhang, Tao Yang, Yuxiang Wu, Yinfeng Qiu, Le Zhang, Fei Li, Minjie Chen, Qili Chen, Wenbin Wei, et al.differentiation of PDLSCs was induced by supplementing the culture medium with 50 ng/mL EGF (cat. no. ab259398, Abcam, USA) and 50 ng/mL FGF-2, with medium changed every 2 days for a total of 10 days, as previously

(2) Uromodulin alleviates fibrosis in acute kidney injury to chronic kidney disease transition by reducing EGFRCell Commun SignalDecember 29, 2025Zheyu Xing, Kunjing Gong, Na Wang, Lufeng Bai, Nan Hu, Di Song, Yuqing Chen16 gradients and mixed with labeled EGFR at a 1:1 ratio respectively. Recombinant human EGF protein (ab259398, Abcam, UK) was used as the positive control and diluted from 41.5 µM. Bovine serum albumin (BSA) (A9418,

(3) SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Enzalutamide Resistance and Metastatic Potential in Prostate CancerCancer Genomics ProteomicsOctober 28, 2025Wei-Lun Huang, Pei-Fang Hsieh, Sih-Han Chen, Richard Chen-Yu Wu, Hsing-Cha Mai, Chun-Hsien Wu, See-Tong Pang, Yu-Lin Yang, Victor Chia-Hsiang Lin(MedChem Express, MDV3100, Monmouth Junction, NJ, USA). EGF treatment. Recombinant human EGF (Abcam, ab259398, Cambridge, UK) was reconstituted in phosphate-buffered saline containing 0.1% bovine serum albumin

(4) Systematic Comparison of FBS and Medium Variation Effect on Key Cellular Processes Using Morphological ProfilingCellsFebruary 25, 2025Timofey Lebedev, Alesya Mikheeva, Valentina Gasca, Pavel Spirin, Vladimir Prassolovon serum-free media, and after an additional 24 h, we added either 100 ng/mL recombinant human EGF (ab259398, Abcam, Cambridge, UK) or 0.001% BSA for control. The ERK1/2 activity was measured with an ERK-KTR-mClover

(5) Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progressionCancer Gene TherapyJuly 1, 2024Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, et al.(all Thermo Fisher Scientific) [13]. In the rescue experiment, PDGF-BB (MBL QK044-0050) or EGF (Abcam ab259398) was added to the medium the day after siRNA knockdown. The number of viable cells was estimated at

Be the First to Write a Review!

Recombinant human EGF protein (Active) from Abcam

Abcam

Citations (5)

Reviews

Recombinant human EGF protein (Active) from Abcam

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map